Related Articles
Feasibility and safety of platinum‑doublet therapy in patients with small‑cell lung cancer in the third‑line setting: <br />A multi‑institutional retrospective study
Paclitaxel for relapsed small‑cell lung cancer patients with idiopathic interstitial pneumonias
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer
RELATIONSHIP BETWEEN RESPONSE RATE AND MEDIAN SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF ONCONASE(R) WITH OTHER ANTICANCER AGENTS
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma